← Back to Search
A Review On The Strategies For Oral Delivery Of Proteins And Peptides And Their Clinical Perspectives
Abdul Muheem, F. Shakeel, M. A. Jahangir, M. Anwar, N. Mallick, G. Jain, M. Warsi, F. Ahmad
Published 2016 · Biology, Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
In the modern world, a number of therapeutic proteins such as vaccines, antigens, and hormones are being developed utilizing different sophisticated biotechnological techniques like recombinant DNA technology and protein purification. However, the major glitches in the optimal utilization of therapeutic proteins and peptides by the oral route are their extensive hepatic first-pass metabolism, degradation in the gastrointestinal tract (presence of enzymes and pH-dependent factors), large molecular size and poor permeation. These problems can be overcome by adopting techniques such as chemical transformation of protein structures, enzyme inhibitors, mucoadhesive polymers and permeation enhancers. Being invasive, parenteral route is inconvenient for the administration of protein and peptides, several research endeavors have been undertaken to formulate a better delivery system for proteins and peptides with major emphasis on non-invasive routes such as oral, transdermal, vaginal, rectal, pulmonary and intrauterine. This review article emphasizes on the recent advancements made in the delivery of protein and peptides by a non-invasive (peroral) route into the body.
This paper references
Keynote review: intestinal Peyer's patch M cells and oral vaccine targeting.
D. Brayden (2005)
Protein and peptide drug delivery: oral approaches. Ind
J Shaji (2008)
The Production and Evaluation of Orally Administered Insulin Nanoparticles
R. Oppenheim (1982)
The androgen receptor in hormone-refractory prostate cancer: relevance of different mechanisms of androgen receptor signaling (Review).
M. V. Cronauer (2003)
Oral Delivery of Biologically Active Parathyroid Hormone
A. Leone-Bay (2004)
Matrix metalloproteinase expression and function during fin regeneration in zebrafish: analysis of MT1-MMP, MMP2 and TIMP2.
Shan Bai (2005)
Enhancing effect of chitosan on peptide drug delivery across buccal mucosa.
S. Şenel (2000)
Oral peptide drug delivery: polymer-inhibitor conjugates protecting insulin from enzymatic degradation in vitro.
M. Marschütz (2000)
Oral Delivery of Peptide Drugs
J. Hamman (2012)
Transport of IGF-I across epithelial cell monolayers.
S. Bastian (1999)
Transmucosal macromolecular drug delivery.
C. Prego (2005)
Oral delivery of therapeutic proteins and peptides: a review on recent developments
S. Gupta (2013)
The effect of protein
R. A. Judge (1998)
Transport of nanoparticles across an in vitro model of the human intestinal follicle associated epithelium.
A. des Rieux (2005)
Oral delivery of vaccines using polymerized liposomes
R. C. Oppenheim
Biodegradable nanoparticles containing protein‐fatty acid complexes for oral delivery of salmon calcitonin
H. Yoo (2004)
Comparison of monomeric
C. J. Lim (2005)
Oral delivery of proteins by biodegradable nanoparticles.
S. Bakhru (2013)
Oral colon-specific drug delivery: a review
G. Mooter (1995)
Oral insulin – a review
K. Anand (2010)
Current challenges in non-invasive insulin delivery systems: a comparative review.
E. Khafagy (2007)
Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial--Type 1.
J. Skyler (2005)
Biologically erodable microspheres as potential oral drug delivery systems
E. Mathiowitz (1997)
Approaches for enhancing oral bioavailability of peptides and proteins.
J. Renukuntla (2013)
Formulation and characterization of an oily-based system for oral delivery of insulin.
A. Elsayed (2009)
Absorption of Polyethylene Glycols 600 Through 2000: The Molecular Weight Dependence of Gastrointestinal and Nasal Absorption
M. Donovan (2004)
Investigation of the enhancing mechanism of sodium N-[8-(2-hydroxybenzoyl)amino]caprylate effect on the intestinal permeability of polar molecules utilizing a voltage clamp method.
Shmuel Hess (2005)
A. De la Taille (2003)
Novel Bioadhesive Chitosan-EDTA Conjugate Protects Leucine Enkephalin from Degradation by Aminopeptidase N
A. Bernkop-Schnürch (2004)
Current prodrug design for drug discovery.
Pei-Wen Hsieh (2009)
Self-assembled “nanocubicle” as a carrier for peroral insulin delivery
H. Chung (2001)
Oral protein delivery: Current status and future prospect
K. Park (2011)
Poly (lactide-co-glycolide) particles of different physicochemical properties and their uptake by peyer's patches in mice.
Monjed Shakweh (2005)
Oral peptide and protein delivery: unfulfilled promises?
W. Shen (2003)
Challenges for the oral delivery of macromolecules
M. Goldberg (2003)
MMP2 and TIMP2
S. H. Bakhru (2013)
The Buccal Delivery of Insulin
Towards an oral influenza vaccine.
P. J. Sizer (1997)
Development and in vivo evaluation of an oral insulin-PEG delivery system.
P. Calceti (2004)
Structure-function engineering of interferon-beta-1b for improving stability, solubility, potency, immunogenicity, and pharmacokinetic properties by site-selective mono-PEGylation.
A. Basu (2006)
Development of a Gas Empowered Drug Delivery system for peptide delivery in the small intestine.
A. Sadeghi (2009)
Develop - ment of acrylic - based copolymers for oral insulin delivery
J. M. Gamboa (2008)
Methodo - logical and cellular aspects that govern the internalization mechanisms of arginine - rich cell - penetrating peptides
Protein and Peptide Drug Delivery: Oral Approaches
J. Shaji (2008)
Degradation of Insulin and Calcitonin and Their Protection by Various Protease Inhibitors in Rat Caecal Contents: Implications in Peptide Delivery to the Colon
H. Tozaki (1997)
In vitro and in vivo models for
J. M. Gamboa (2013)
Current Status of the Oral Delivery of Insulin
V. Agarwal (2001)
pH-Sensitive Nanoparticles: An Effective Means to Improve the Oral Delivery of HIV-1 Protease Inhibitors in Dogs
J. Leroux (2004)
Niosomes for oral delivery of peptide drugs
H. Yoshida (1992)
Calcium alginate microparticles for oral administration: I: Effect of sodium alginate type on drug release and drug entrapment efficiency.
S. Takka (1999)
Oral delivery of therapeutic protein/peptide for diabetes--future perspectives.
M. Rekha (2013)
Prodrug design to improve pharmacokinetic and drug delivery properties: challenges to the discovery scientists.
S. Jana (2010)
Drug delivery in diabetes : oral - lyn needle - free buccal delivery of insulin
Principles of transmucosal delivery of therapeutic agents.
J. Blanchette (2004)
The effect of the
C. McGrath (1997)
Emerging trends in oral delivery of peptide and protein drugs.
R. Mahato (2003)
Oral Delivery of Vaccines
D. O'hagan (1992)
Vitamin B12 as a Carrier for the Oral Delivery of Insulin
Amanda K. Petrus (2007)
Region-Dependent Role of the Mucous/Glycocalyx Layers in Insulin Permeation Across Rat Small Intestinal Membrane
Y. Aoki (2005)
Sandimmun neoral pharmacokinetics: impact of the new oral formulation.
D. Holt (1995)
Oral delivery of macromolecules: rationale underpinning Gastrointestinal Permeation Enhancement Technology (GIPET).
E. Walsh (2011)
New development in insulin delivery
M. Kidron (2004)
A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancers to the intestinal mucosa.
Abdallah Makhlof (2011)
Cell Internalization of the Third Helix of the Antennapedia Homeodomain Is Receptor-independent*
D. Derossi (1996)
Oral peptide delivery: prioritizing the leading technologies.
D. Brayden (2011)
Spray-dried redispersible oil-in-water emulsion to improve oral bioavailability of poorly soluble drugs.
G. Dollo (2003)
Novel crystalline catalysts
A. Margolin (1996)
Oral peptide delivery: prioritizing
D. J. 142–151. Brayden (2011)
Modulation of intestinal tight junctions by Zonula occludens toxin permits enteral administration of insulin and other macromolecules in an animal model.
A. Fasano (1997)
Design of nanoparticles composed of graft copolymers for oral peptide delivery.
S. Sakuma (2001)
An ester bond linking a fragment of a serine proteinase to its serpin inhibitor.
R. Egelund (1998)
Methodological and cellular aspects that govern the internalization mechanisms of arginine-rich cell-penetrating peptides.
I. Nakase (2008)
Pharmaceutical Combinations And Related Methods Of Delivery. (LandoAndAnastasi), USP Application 01056275A1
P. Salama (2010)
MUCOADHESIVE POLYMERS IN PERORAL PEPTIDE DRUG DELIVERY. I. INFLUENCE OF MUCOADHESIVE EXCIPIENTS ON THE PROTEOLYTIC ACTIVITY OF INTESTINAL ENZYMES
H. L. Luessen (1996)
Chitosan - based gastrointestinal delivery system
S. Hess (2003)
Dose-response effect of a single administration of oral hexyl-insulin monoconjugate 2 in healthy non-diabetic subjects
E. Wajberg (2004)
Peroral route: an opportunity for protein and peptide drug delivery.
A. Sood (2001)
Protein therapeutics: a summary and pharmacological classification
B. Leader (2008)
Biologically erodible microspheres
Calcium alginate microparticles for oral administration: II. Effect of formulation factors on drug release and drug entrapment efficiency.
F. Acartürk (1999)
A novel per‐oral insulin formulation: proof of concept study in non‐diabetic subjects
M. Kidron (2004)
Release and bioactivity of PACA nanoparticles containing D-Lys⁶-GnRH for brushtail possum fertility control.
Alexandra P Kafka (2011)
Comparative bioavailability of two brands of cyclosporin
A. Sachdeva (1997)
Techniques: new approaches to the delivery of biopharmaceuticals.
G. Orive (2004)
Oral insulin – a review of current status
H. Iyer (2010)
Mucoadhesive drug delivery systems
Rahamatullah Shaikh (2011)
on additional clinical data from oral cyclosporine trial (Novartis)
Models to predict intestinal absorption of therapeutic peptides and proteins.
Filipa Antunes (2013)
Biologically erodible microspheres as potential oral drug delivery systems
Sandimmune nerol pharmacokinetics: impact
K. Kutz (1995)
Oral delivery of proteins: progress and prognostication.
R. Shah (2002)
Safety and efficacy of sodium caprate in promoting oral drug absorption: from in vitro to the clinic.
S. Maher (2009)
Lessons Learned From the Development of Oral Calcitonin: The First Tablet Formulation of a Protein in Phase III Clinical Trials
M. Karsdal (2011)
In vitro and in vivo models for the study of oral delivery of nanoparticles.
J. Gamboa (2013)
New Approach for Oral Administration of Insulin With Polyalkylcyanoacrylate Nanocapsules as Drug Carrier
C. Damgé (1988)
Biodegradable nanoparticles containing protein-fatty acid complexes for oral delivery of salmon calcitonin.
Hyuk Sang Yoo (2004)
A Five Period, Open Label, Placebo Controlled
P. Kumar (2009)
Comparative bioavailability of two brands of cyclosporine
A. Sachdeva (1997)
Targeted lipid based drug conjugates: a novel strategy for drug delivery.
A. D. Vadlapudi (2012)
The effect of protein impurities on lysozyme crystal growth.
R. Judge (1998)
Polymeric nanoparticles for drug delivery.
J. M. Chan (2010)
G. Strous (1992)
Tight junction modulation and its relationship to drug delivery.
N. Salama (2006)
A 2-week randomized, active comparator study of two HDV-Insulin routes (SC and oral) and SC human insulin in patients with type 1 diabetes mellitus
S. Schwartz (2008)
Thiomers: a new generation of mucoadhesive polymers.
A. Bernkop-Schnürch (2005)
The effect of various liposome formulations on insulin penetration across Caco-2 cell monolayer.
Z. Değim (2004)
Z. Sauna (2017)
Approaches and opportunities in colon-specific drug delivery.
A. Rubinstein (1995)
Evaluation of skin damage caused by percutaneous absorption enhancers using fractal analysis.
Y. Obata (2000)
Novel human-derived cell-penetrating peptides for specific subcellular delivery of therapeutic biomolecules.
C. de Coupade (2005)
Cell Penetrating Peptides in the Delivery of Biopharmaceuticals
Were LL Munyendo (2012)
Intestinal permeation enhancers.
B. Aungst (2000)
Sandimmune nerol pharmacokinetics : impact of new oral formulation
P. W. Hsieh (1995)
Development of acrylic-based copolymers for oral insulin delivery.
Aaron C Foss (2004)
Incretin-based therapies: review of current clinical trial data.
A. Peters (2010)
Comparative bioavailability of two brands of cyclosporine. Ind
A Sachdeva (1997)
Oral peptide drug
Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo.
Yan Pan (2002)
Emerging trends in oral delivery of peptide and proteins
S. Maher (2009)
Effects of Various Protease Inhibitors on the Intestinal Absorption and Degradation of Insulin in Rats
A. Yamamoto (2004)
Is the oral route possible for peptide and protein drug delivery?
M. Morishita (2006)
Source Apollo life sciences
A new drug carrier, Nα-deoxycholyl-l-lysyl-methylester, for enhancing insulin absorption in the intestine
S. Lee (2004)
Comparison of monomeric and oligomeric transferrin as potential carrier in oral delivery of protein drugs.
Ching J Lim (2005)
Novel human-derived cell-penetrating
E Tasciotti (2005)
P-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancement.
M. Varma (2003)
Mucoadhesive drug delivery systems
F. Carvalho (2010)
Dose-response effect of a single administration of oral hexyl-insulin monoconjugate 2 in healthy nondiabetic subjects.
E. Wajcberg (2004)
The use of mucoadhesive polymers in buccal drug delivery.
Nazila Salamat-Miller (2005)
Transport of human growth hormone across Caco-2 cells with novel delivery agents: evidence for P-glycoprotein involvement.
S. J. Wu (1999)
Advanced drug delivery: perspectives and prospects. Preface.
V. Lee (2013)
Improvement of intestinal absorption of leucine enkephalin by sugar coupling and peptidase inhibitors.
T. Mizuma (1996)
insulin absorption in the intestine
V. M. Leitner (2003)
Controlled release by using poly(methacrylic acid-g-ethylene glycol) hydrogels
N. Peppas (1991)
Drug delivery and targeting.
R. Langer (1998)
Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract.
A. Bernkop-Schnurch (1997)
Cell-penetrating peptides: mechanism and kinetics of cargo delivery.
M. Zorko (2005)
Design and evaluation of a chitosan–aprotinin conjugate for the peroral delivery of therapeutic peptides and proteins susceptible to enzymatic degradation
M. Werle (2007)
Chitosan-based gastrointestinal delivery systems.
Radi Hejazi (2003)
Pglycoprotein inhibitors and their screening: a perspective from bioavailability
M.V.S. Varma (2003)
Control of postprandial plasma glucose by an oral insulin product (HIM2) in patients with type 2 diabetes.
M. Kipnes (2003)
Oral insulin product hexyl-insulin monoconjugate 2 (HIM2) in type 1 diabetes mellitus: the glucose stabilization effects of HIM2.
S. Clement (2002)
Lipid Microemulsions for Improving Drug Dissolution and Oral Absorption: Physical and Biopharmaceutical Aspects
P. Constantinides (2004)
Analysis of the complexation/decomplexation phenomena in graft copolymer networks
A. Lowman (1997)
Cell penetrating peptides in the delivery
J. Zhou (2012)
A novel per-oral insulin
M Goldberg (2004)
Lecithin-Based Microemulsion of a Peptide for Oral Administration: Preparation, Characterization, and Physical Stability of the Formulation
A. Cilek (2006)
Hypoglycemic effect of surfactant-coated insulin solubilized in a novel solid-in-oil-in-water (S/O/W) emulsion.
Eiichi Toorisaka (2003)
Lessons learned from the development
M. R. John (2011)
The Future of Peptide‐based Drugs
D. Craik (2013)
Carrier-enhanced human growth hormone absorption across isolated rabbit intestinal tissue.
G. M. Mlynek (2000)
New Developments in Insulin Delivery
N. Ghilzai (2003)
Oral protein delivery: current
K. Park (2011)
Absorption Of Orally Ingested Insulin In Human Type 1 Diabetic Subjects: Proof Of Concept Study
C. D. Whitelaw (2005)
The androgen receptor in hormone-refractory prostate cancer.
H. Mao (2009)
Nanosphere based oral insulin delivery.
G. Carino (2000)
An ester bond linking a fragment of a serine proteinase to its serpin inhibitor.
Rikke Egelund (1998)
Oral delivery of biologically active
M Carozza (2001)
Mucoadhesive polymers in peroral
Noninvasive insulin delivery: the great potential of cell-penetrating peptides.
N. Kamei (2013)
Estimation of permeability by passive diffusion through Caco-2 cell monolayers using the drugs' lipophilicity and molecular weight.
G. Camenisch (1998)
Use of Targeting Agents to Increase Uptake and Localization of Drugs to the Intestinal Epithelium
G. J. Russell-Jones (2004)
Thiolated polymers: evidence for the formation of disulphide bonds with mucus glycoproteins.
V. Leitner (2003)
In vitro models for selection of development candidates. Permeability studies to define mechanisms of absorption enhancement
E. Lecluyse (1997)
Novel iron-polysaccharide multilayered microcapsules for controlled insulin release.
J. Zheng (2009)
This paper is referenced by
A liquid chromatography high‐resolution mass spectrometry in vitro assay to assess metabolism at the injection site of subcutaneously administered therapeutic peptides
S. Esposito (2018)
Design and synthesis of selective MMP-9 inhibitors for the treatment of epilepsy
Alexandra Bertran Junqué (2018)
A Brief Overview of the Oral Delivery of Insulin as an Alternative to the Parenteral Delivery.
A. Macedo (2020)
The biological challenges and pharmacological opportunities of orally administered nanomedicine delivery
D. Moss (2018)
Basic concepts and recent advances in nanogels as carriers for medical applications
I. Neamţu (2017)
Polyaminoacid-based nanocarriers: a review of the latest candidates for oral drug delivery
Sandra Robla (2020)
I. INTERNSHIP REPORT IN COMMUNITY PHARMACY
Joana Rafaela Sousa Barbosa (2017)
Extraction, identification, and structure–activity relationship of antioxidative and α-amylase inhibitory peptides from cumin seeds (Cuminum cyminum)
Hwee-Leng Siow (2016)
Overcoming barriers confronting application of protein therapeutics in bone fracture healing
T. Czech (2020)
Enhanced Oral Vaccine Efficacy of Polysaccharide-Coated Calcium Phosphate Nanoparticles
Pei Cao (2020)
Oral peptide delivery: Translational challenges due to physiological effects
Puneet Tyagi (2018)
Challenges in the local delivery of peptides and proteins for oral mucositis management
João Campos (2018)
Daptomycin Proliposomes for Oral Delivery: Formulation, Characterization, and In Vivo Pharmacokinetics
Javier Rueda Arregui (2018)
Stability of Cu(ii) complexes with FomA protein fragments containing two His residues in the peptide chain.
M. Lesiów (2019)
A Review: Overview of Novel Polyelectrolyte Complexes as Prospective Drug Bioavailability Enhancers
M. Siyawamwaya (2015)
Ocular delivery of proteins and peptides: Challenges and novel formulation approaches☆
A. Mandal (2018)
Nanotechnology in insulin delivery for management of diabetes.
Fatemah Bahman (2019)
Evaluation of the oral delivery of goserelin with Pheroid® technology
L. Erasmus (2017)
Recent avenues in Novel Patient-Friendly Techniques for the Treatment of Diabetes.
S. K. Dubey (2019)
Alginate/chitosan microparticles for gastric passage and intestinal release of therapeutic protein nanoparticles
Kevin Ling (2019)
Pharmacokinetic evaluation of novel pH‐sensitive poly(2‐methoxyethyl methacrylate‐co‐itaconic acid) microgels in rabbits
Zermina Rashid (2018)
Intestinal Drug Absorption Enhancement by Aloe vera Gel and Whole Leaf Extract: In Vitro Investigations into the Mechanisms of Action
Anja Haasbroek (2019)
Overview of the Advantages and Disadvantages of Different Mucosal Sites for the Delivery of Nanoparticles
K. Kaneko (2020)
Targeting Kinase Interaction Networks: A New Paradigm in PPI Based Design of Kinase Inhibitors.
P. Jenardhanan (2019)
Drug delivery: advancements and challenges
Narinder Singh (2017)
Long-term delivery of protein and peptide therapeutics for cancer therapies
Sadia Sikder (2019)
Ocular Delivery of Peptides and Proteins
R. Dahiya (2018)
Mohsen Doostmohammadi (2019)
Loading and coating of microcontainers for oral drug delivery
C. Mazzoni (2019)
An ex vivo investigation of the potential drug permeation enhancing effects of selected pepper extracts
V. Niekerk (2019)
Ionic Liquids and Deep Eutectic Solvents for Enhanced Delivery of Antibodies in the Gastrointestinal Tract
Pavimol Angsantikul (2020)
β-galactosidase Encapsulated in Carrageenan, Pectin and Carrageenan/Pectin: Comparative Study, Stability and Controlled Release.
R. C. Silva (2020)See more